Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children
NCT ID: NCT03013517
Last Updated: 2020-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
300 participants
INTERVENTIONAL
2017-01-23
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Viaskin Peanut 250µg
Viaskin Peanut 250µg
DBV712 250 µg, once daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Viaskin Peanut 250µg
DBV712 250 µg, once daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Diagnosis of asthma that evolved to severe, unstable or uncontrolled asthma.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DBV Technologies
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arkansas Children's Hospital
Little Rock, Arkansas, United States
University of California, Rady Children's Hospital
San Diego, California, United States
Stanford University School of Medicine
Stanford, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
National Jewish Health
Denver, Colorado, United States
Ann & Robert Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Boston Childrens' Hospital
Boston, Massachusetts, United States
Jaffe Food Allergy Institute
New York, New York, United States
The University of North Carolina - Chapell Hill
Chapel Hill, North Carolina, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Children's Medical Center of Dallas
Dallas, Texas, United States
Baylor College of Medicine - Texas Children's Hospital
Houston, Texas, United States
ASTHMA, Inc.
Seattle, Washington, United States
Allergy Medical
Brisbane, , Australia
Princess Margaret Hospital for Children
Perth, , Australia
Children's Hospital Westmead
Sydney, , Australia
British Columbia Children's Hospital
Vancouver, British Columbia, Canada
Cheema Research Inc.
Mississauga, Ontario, Canada
Ottawa Allergy Asthma Research Institute
Ottawa, Ontario, Canada
Gordon Sussman Clinical Research Inc.
Toronto, Ontario, Canada
CHUM & CHU Sainte-Justine
Montreal, Quebec, Canada
Centre de Recherche Appliquée en Allergie de Quebec
Québec, , Canada
Charité Universitätsmedizin Berlin
Berlin, , Germany
St.-Marien-Hospital
Bonn, , Germany
Universitätsklinikum Erlangen
Erlangen, , Germany
Clinical Investigations Unit
Cork, , Ireland
Our Lady's Children's Hospital
Dublin, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEOPLE
Identifier Type: -
Identifier Source: org_study_id